Sponsor Dossier
Gedeon Richter
Sponsor Dossier for Gedeon Richter. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: AFOLIA
- Brand: BEMFOLA
- Brand: CYCLOGEST
- Brand: GANIRELIX
- Brand: POSTINOR-1
- Brand: RYEQO
- Brand: TERROSA
- Brand: ZAFRILLA
- Device (sponsor): Prefilled self-injector, single-dose
- Device (sponsor): Prefilled self-injector, single-dose
- Device (sponsor): Basic insulin pen, replaceable-cartridge
- Device (sponsor): Basic insulin pen, replaceable-cartridge
- Device (sponsor): Medicine administration kit, percutaneous, medicated, single-use
- Device (sponsor): Medicine administration kit, percutaneous, medicated, single-use
- Device (sponsor): Needle, injector, medication/vaccine
About
Gedeon Richter is an Australian Private Company with ABN 98 602 550 274, registered in New South Wales. The company is active and GST-registered.
Portfolio
Gedeon Richter has 8 brands on the ARTG, of which 6 are indexable and 5 carry a Product Information document. 3 brands are PBS-listed, 4 have a PBAC outcome on record, and 2 have an AusPAR on record. Notable brands include AFOLIA, BEMFOLA, CYCLOGEST, GANIRELIX, POSTINOR-1, RYEQO, TERROSA, ZAFRILLA.
Therapeutic focus
— Reproductive Health: 7 brands — Musculoskeletal: 1 brand
PBS footprint
3 brands are PBS-listed, with the latest PBS schedule date 2026-10-01.
Regulatory activity
The latest PBAC outcome is 2024-11-01, across 4 brands with a PBAC outcome on record. The latest AusPAR is 2016-04-12, across 2 brands with an AusPAR on record.